NUDCD1

Across TCGA pan-cancer cohorts, NUDCD1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated NUDCD1 data layer compared with 22 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher NUDCD1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated NUDCD1 expression acts as an unfavorable survival marker, although some lineages such as LSCC show a favorable association.

CCRCC, HNSC, and LSCC are the cancer types where NUDCD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	II,III,IV	0.603	0.872	.005	15	view →
HNSC	OS	Quartile	All	0.783	0.964	.007	8	view →
LSCC	DFS	Median	II,III,IV	0.813	0.564	.036	3	view →
PDAC	OS	Median	All	0.715	0.909	.024	3	view →
LUAD	DFS	Median	All	0.505	0.899	.015	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

NUDCD1–CCRCC (OS)

Open the CCRCC breakdown →